Advances in the pharmacological management of neutropenia in solid tumors: the advent of biosimilars

Ghidini, Michele; Indini, Alice; Nigro, Olga; Polito, Simona; Rijavec, Erika; Petrelli, Fausto; Tomasello, Gianluca

doi:10.1080/14656566.2021.1873950

Search citation statements

Order By: Relevance

Paper Sections

Select...

Biosimilars Of Filgrastim and Pegfilgrastim1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 81 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several biosimilars of the originator drugs filgrastim and pegfilgrastim are now approved in different regions of the world [70][71][72], several of them according to the strict requirements of the US Food and Drug Administration (FDA) and European Medicines Agency (EMA). There are no differences in clinical efficacy and side effects compared to the original filgrastim or pegfilgrastim preparation [73]. Approved biosimilars of filgrastim can also be used for stem cell mobilization in healthy individuals [20].…”

Section: Biosimilars Of Filgrastim and Pegfilgrastimmentioning

confidence: 99%